Abstract
K- ras activation by point mutation in codon 12 has been reported in lung adenocarcinomas in various models of experimental lung tumours induced by chemical carcinogens. The hypothesis of the presence of cells containing K- ras mutation in non neoplastic bronchial carina, the main site of impaction of airborne contaminants, was investigated by evaluating concurrent lung tumour and non-neoplastic proximal bronchial carinae from 19 patients with lung adenocarcinomas. The restriction fragment length polymorphism enriched PCR method used can detect one mutant allele among 103 normal alleles. A mutation was detected in 42% of lung adenocarcinoma samples. No mutation was detected in either tumour or bronchial carinae in nine patients (47%). K- ras mutation was detected in the lung tumour but not in bronchial carinae in four patients (21%), in both the lung tumour and bronchial carinae in four other patients (21%). In two patients (11%), K- ras mutation was detected in at least one bronchial carina, but not in the lung tumour. Mutations of codon 12, confirmed by sequencing analysis of ten samples, were G to T transversion, mostly TGT and GTT in bronchial carinae and lung tumours. Our data show that activated K- ras by point mutation can be present in non-neoplastic bronchial carina mucosa even when no mutation is detected in tumour samples. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Auerbach O, Hammond EC and Garfinkel L (1979) Changes in bronchial epithelium in relation to cigarette smoking, 1955–1960 vs. 1970–1977. N Engl J Med 300: 381–386
Barbacid M (1987) ras genes. Annu Rev Biochem 56: 779–827
Behn M, Qun S, Pankow W, Havemann K and Schuermann M (1998) Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based ‘enriched PCR’ technique. Clin Cancer Res 4: 361–371
Benett WP, Colby TV, Travis WD, Borkowski A, Jones RT, Lane DP, Metcalf RA, Samet JM, Takeshima Y, GU JR, Vähäkangas KH, Soini Y, Pääkkoö P, Welsh JA, Trump BF and Harris CC (1993) p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 53: 4817–4822
Berthelemy P, Bouisson M, Escourrov J, Vaysse N, Rumeau JL and Pradayrol L (1995) Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 123: 188–191
Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Res 49: 4682–4689
Brentnall TA, Chen R, Lee JG, Kimmey MB, Bronner MP, Haggitt RC, Kondley KV, Hecker LM and Byrd DR (1995) Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res 55: 4264–4267
Burmer GC and Loeb L (1989) Mutations in the K-ras oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci USA 86: 2403–2407
Carney DN (1991) Lung cancer biology. Curr Opin Cancer 3: 288–296
Carothers AM and Grunberger D (1990) DNA base changes in benzo(a)pyrene diol epoxide-induced dihydrofolate reductase mutants of chinese hamster ovary cells. Carcinogenesis 11: 189–192
Clements NC, Nelson MA, Wymer JA, Savage C, Aguirre M and Garewal H (1995) Analysis of K-ras gene mutations in malignant and non-malignant endobronchial tissue obtained by fiberoptic bronchoscopy. Am J Respir Crit Care Med 152: 1374–1378
Denissenko MF, Pao A, Tang MS and Pfeifer GP (1996) Preferential formation of benzo(a)pyrene at lung cancer mutational hotspots in P53. Science 274: 430–432
Hruban RH, Van Mansfeld ADM, Offerhaus GJA, Van Weering DH, Alison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL and Bos JL (1993) K-ras oncogene activation in adenocarcinoma of the human pancreas. Am J Pathol 143: 545–554
Husafvel-Pursiaisen K, Hackman P, Ridanpää M, Anttilas S, Karjalainen A, Tartanen T, Taikina-Aho O, Heikkila L and Vainio H (1993) K-ras mutations in human adenocarcinoma of the lung with smoking and occupational exposure to asbestos. Int J Cancer 53: 250–256
Jiang W, Khan SM, Guillem JG, Lu SH and Weinstein B (1989) Rapid detection of ras oncogenes in human tumors: applications to colon, oesophageal, and gastric cancer. Oncogene 4: 923–928
Kitamura S and Kobayashi J (1995) Atlas and basic technique. In: Textbook of Bronchoscopy, Feinsilver SH, Fein AM (eds), pp. 31–48. Williams and Wilkins: Baltimore
Khan SM, Jiang WJ, Culbertson TA, Weinstein B, Williams GM, Tomita N and Ronai Z (1991) Rapid and sensitive detection of mutant K-ras genes via ‘enriched’ PCR amplification. Oncogene 6: 1079–1083
Knudson KP (1960) The pathologic effects of smoking tobacco in the trachea and bronchial mucosa. Am J Clin Path 33: 310–317
Kobayashi T, Tsuda H, Noguchi M, Hirohashi S, Goya T and Hayata Y (1990) Association of point mutation in c-ki-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes. Cancer 66: 289–294
Leone-Klaber S, Wessner LL, McEntee MF, D’Agostino RBJR and Miller MS (1997) Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors. Carcinogenesis 18: 1163–1168
Loeb LA, Ernester VL, Warner KE, Abbotts J and Lazlo J (1984) Smoking and lung cancer: an overview. Cancer Res 44: 5940–5958
Li ZH, Zheng J, Weiss LM and Shibata D (1994) c-K-ras 2 and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol 144: 303–309
Manenti G, De Gregorio L, Pilotti S, Falvella FS, Incarbone M, Ravagnani F, Pierotti MA and Dragani TS (1997) Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis. Carcinogenesis 98: 1917–1920
Mao L, Lee JS, Kurie JM, Kurie JM, Fan YH, Lippman SM, Lee JJ, RO JY, Broxson A, Yu R, Morice RC, Kemp BL, Khuri FR, Walsh GL, Hittelman WN and Hong WK (1997) Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 89: 857–862
Mass MJ, Jeffers AJ, Ross JA, Nelson G, Galati AJ, Stoner GD and Nesnow S (1993) K-ras 2 oncogene mutations in tumors and DNA adducts formed by benz(j)aceanthrylene and benzo(a)pyrene in the lungs of strain A/J mice. Mol Carcinogen 8: 186–192
Minamoto T, Yamashita N, Ochiai A, Mai M, Sugimara T, Ronai Z and Esumi H (1995) Mutant K-ras in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal tumorigenesis. Cancer 75: 1520–1526
Rodenhuis S, Slebos RJC, Boot AJM, Evers SG, Mooi WJ, Wagenaar SSC, Van Bodegom PCh and Bos JL (1988) Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res 48: 5738–5741
Rodenhuis S, Boerrigter L, Top B, Slebos RJ, Mooi WJ, Van’Tveer L and van Zandwijk N (1997) Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study. J Clin Oncol 15: 285–291
Ronai Z, Yabubovskaya MS, Zhang E and Belitsky GA (1996) K-ras mutation in sputum of patients with or without lung cancer. J Cell Biochem 25: 172–176
Rosell R, Li S, Skacel Z, Mate JL, Maestre J, Canela M, Tolosa E, Armengol P, Barnabas A and Ariza A (1993) Prognosis impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Oncogene 8: 2407–2412
Slebos RJC, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJ, Wagenaar SS, Vanderschueren RG, Van Zandwijk N, Mooi WJ, Bos JL and Rodenhuis S (1990) K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 323: 561–565
Slebos RJC, Hruban RH, Dalesio O, Mooi WJ, Offerhaus JA and Rodenhuis S (1991) Relationship between K-ras activation and smoking in adenocarcinoma of the human lung. J Natl Cancer Inst 83: 1024–1027
Sozzi G, Miozzo M, Donghi R, Pilotti S, Cariani CT, Pastorino U, Della Porta G and Pierotti MA (1992) Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 52: 6079–6082
Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM and Rabbitts P (1992) p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7: 1989–1997
Sugio K, Ishida T, Yokoyama H, Inoue T and Sugimachi K Sasazuki (1992) Ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res 52: 2903–2906
Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y and Kawabe T (1996) Analysis of K-ras gene mutations in hyperplastic duct cells of the pancreas without pancreas disease. Gastroenterology 110: 227–231
Urban T, Ricci S, Grange JD, Lacave R, Boudghene F, Breittmayer F, Languille O, Roland J and Bernaudin JF (1993) Detection of c-K-ras 2 mutations by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J Natl Cancer Inst 85: 2008–2012
Urban T, Ricci S, Lacave R, Antoine M, Kambouchner M, Capron F and Bernaudin JF (1996) Codon 12 ki-ras mutation in non-small cell lung cancer: comparative evaluation in tumoural and non-tumoural lung. Br J Cancer 74: 1051–1055
Westra WH, Slebos RJC, Offerhaus GJA, Goodman SN, Evers SG, Kensler TW, Askin FB, Rodenhuis S and Hruban RH (1993) K-ras oncogene activation in lung adenocarcinomas from former smokers. Cancer 72: 432–438
Wilentz RE, Chung C, Sturm PDJ, Musler A, Sohn TA, Offerhaus GJ, Yeo CJ and Hruban RH (1998) K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Cancer 82: 96–103
Yanagisawa A, Ohtake K, Ohashi K, Hori M, Kitagawa T, Sugano H and Kato Y (1993) Frequent c-K-ras oncogene activation in mucous cell hyperplasia of pancreas suffering from chronic inflammation. Cancer Res 53: 953–956
You M, Candrian U, Maronpot RR, Stoner GD, Marshall W and Anderson W (1989) Activation of the k-ras 2 proto-oncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc Natl Acad Sci USA 86: 3070–3074
You M, Wang Y, Stoner G, You L, Maronpot R, Reynolds SH and Anderson M (1992) Parental bias of K-ras oncogenes detected in lung tumors from mouse hybrids. Proc Natl Acad Sci USA 89: 5804–5808
You M, Wang Y, Nash B and Stoner GD (1993) K-ras mutations in benzotrochloride-induced lung tumors of A/J mice. Carcinogenesis 14: 1247–1249
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Urban, T., Ricci, S., Danel, C. et al. Detection of codon 12 K- ras mutations in non-neoplastic mucosa from bronchial carina in patients with lung adenocarcinomas. Br J Cancer 82, 412–417 (2000). https://doi.org/10.1054/bjoc.1999.0935
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.0935
Keywords
This article is cited by
-
Targeted therapies: how personal should we go?
Nature Reviews Clinical Oncology (2012)
-
Molecular biology and riddle of cancer: the ‘Tom & Jerry’ show
Oncology Reviews (2011)
-
Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia
Eye (2005)
-
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer
Oncogene (2002)